Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NanoScale Corporation, formerly known as NanoScale Materials, was a specialized biotechnology and advanced materials company focused on the development of high-performance nanoparticle-based products. The company's core technology, NanoActive, utilized metal oxide nanoparticles with high surface areas and unique chemical reactivity for applications in decontamination, catalysis, and healthcare. In the life sciences sector, NanoScale developed specialized materials for wound care and infection control, leveraging the antimicrobial properties of its proprietary nanoparticles. The company was acquired by Pressure BioSciences in 2014, which integrated NanoScale's intellectual property into its Ultra Shear Technology (UST) platform for the production of high-quality nanoemulsions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NanoScale.